sulfanilamide has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moskalik, MY | 1 |
1 review available for sulfanilamide and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Sulfonamides with Heterocyclic Periphery as Antiviral Agents.
Topics: Anti-Bacterial Agents; Antiviral Agents; COVID-19; Humans; Indicators and Reagents; Nitrogen; SARS-C | 2022 |